SFTPC and interstitial lung disease: For example, surfactant protein C and Krebs von den Lungen-6 have been studied as biomarkers for interstitial lung diseases, including those with cystic manifestations.[32] Genetic biomarkers: Genetic mutations can play a role in the development of DCLDs.